On Innovative Behavior of State-owned Pharmaceutical Enterprises from the Perspective of Ownership Structure Reform

doi:10.16153/j.1002-7777.2018.02.003

Wang Guangping, Shi Shengyi, Huo Yanfei, Jiang Bin

Chinese Pharmaceutical Affairs ›› 2018, Vol. 32 ›› Issue (2) : 172-179.

PDF(1410 KB)

Chinese Pharmaceutical Affairs ›› 2018, Vol. 32 ›› Issue (2) : 172-179. DOI: 10.16153/j.1002-7777.2018.02.003

On Innovative Behavior of State-owned Pharmaceutical Enterprises from the Perspective of Ownership Structure Reform

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

Abstract

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2018, 32(2): 172-179 https://doi.org/10.16153/j.1002-7777.2018.02.003

References

List( Publishing order | Descend order by publishing year | Descend order by cited within ) Chart analysis

References

Funding

RIGHTS & PERMISSIONS

PDF(1410 KB)

Accesses

Citation

Detail

Sections

Recommended

Please choose a citation manager

Content to export